Takako Inoue

2.0k total citations
100 papers, 1.4k citations indexed

About

Takako Inoue is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Takako Inoue has authored 100 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 53 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Takako Inoue's work include Lung Cancer Treatments and Mutations (49 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Cancer Genomics and Diagnostics (17 papers). Takako Inoue is often cited by papers focused on Lung Cancer Treatments and Mutations (49 papers), Cancer Immunotherapy and Biomarkers (22 papers) and Cancer Genomics and Diagnostics (17 papers). Takako Inoue collaborates with scholars based in Japan, United States and Netherlands. Takako Inoue's co-authors include Fumio Imamura, Kazumi Nishino, Toru Kumagai, Motohiro Tamiya, Tetsukichi Niwaguchi, Madoka Kimura, Kei Kunimasa, Tomonori Hirashima, Shinji Atagi and Akihiro Tamiya and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Takako Inoue

91 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Takako Inoue Japan	20	841	741	300	295	97	100	1.4k
Siyu Wang China	21	631 0.8×	890 1.2×	200 0.7×	274 0.9×	70 0.7×	131	1.5k
Stephen N. Birrell Australia	18	769 0.9×	551 0.7×	591 2.0×	481 1.6×	167 1.7×	34	1.7k
Alesha Thai Australia	5	610 0.7×	762 1.0×	413 1.4×	734 2.5×	63 0.6×	9	1.6k
Kiyoshi Okamoto Japan	15	514 0.6×	331 0.4×	267 0.9×	611 2.1×	200 2.1×	55	1.7k
Judit Moldvay Hungary	20	735 0.9×	599 0.8×	247 0.8×	447 1.5×	78 0.8×	79	1.3k
Russell Petty United Kingdom	18	389 0.5×	361 0.5×	173 0.6×	498 1.7×	66 0.7×	65	1.3k
Aarti Asnani United States	21	393 0.5×	213 0.3×	107 0.4×	488 1.7×	104 1.1×	59	1.4k
Meghana V. Trivedi United States	20	769 0.9×	319 0.4×	382 1.3×	513 1.7×	40 0.4×	59	1.5k
Graham M. Poage United States	14	887 1.1×	375 0.5×	655 2.2×	830 2.8×	123 1.3×	23	1.8k
P. Delmotte Belgium	20	493 0.6×	470 0.6×	167 0.6×	710 2.4×	276 2.8×	53	1.7k

Countries citing papers authored by Takako Inoue

Since Specialization

Citations

This map shows the geographic impact of Takako Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takako Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takako Inoue more than expected).

Fields of papers citing papers by Takako Inoue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takako Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takako Inoue. The network helps show where Takako Inoue may publish in the future.

Co-authorship network of co-authors of Takako Inoue

This figure shows the co-authorship network connecting the top 25 collaborators of Takako Inoue. A scholar is included among the top collaborators of Takako Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takako Inoue. Takako Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inoue, Takako, Hiroko Setoyama, Takehisa Watanabe, et al.. (2025). Innovative Hepatitis C Screening: Clinical Utility of the HCV Antigen-Antibody Assay in Japan. Japanese Journal of Infectious Diseases. 78(6). 192–198.

Etani, Toshiki, Shuhei Kondo, Nobuhiko Shimizu, et al.. (2024). Multicenter surveillance of the outcomes of and antimicrobial susceptibility to acute cystitis caused by Staphylococcus saprophyticus. Journal of Infection and Chemotherapy. 31(1). 102492–102492.

Nakabori, Tasuku, Kei Kunimasa, Kaori Mukai, et al.. (2024). Feasibility of atezolizumab and bevacizumab combination regimens in patients with hepatocellular carcinoma and lung cancer taking direct oral anticoagulants. Cancer Medicine. 13(12). e7430–e7430. 1 indexed citations

Inoue, Takako, Takashi Akazawa, Kei Kunimasa, et al.. (2024). Potent CTLs can be induced against tumor cells in an environment of lower levels of systemic MFG‐E8. Cancer Science. 115(4). 1114–1128. 3 indexed citations

Kunimasa, Kei, Motohiro Tamiya, Takako Inoue, et al.. (2024). Clinical application of the Lung Cancer Compact PanelTM using various types of cytological specimens in patients with lung cancer. Lung Cancer. 189. 107498–107498. 4 indexed citations

Suzuki, Takanori, Akihiro Tamori, Kentaro Matsuura, et al.. (2024). Clinical usefulness of an ultra-high-sensitivity hepatitis B surface antigen assay to determine the cessation of treatment for HBV reactivation. Annals of Hepatology. 30(1). 101764–101764. 1 indexed citations

Kunimasa, Kei, Shingo Matsumoto, Takahisa Kawamura, et al.. (2023). Clinical application of the AMOY 9-in-1 panel to lung cancer patients. Lung Cancer. 179. 107190–107190. 20 indexed citations

Inoue, Satoko, Mayako Uchida, Keiko Fujita, et al.. (2023). Efficacy and safety of mycophenolate mofetil in treating immune‐related hepatitis induced by immune checkpoint inhibitor use: A retrospective study. JGH Open. 7(2). 87–97. 9 indexed citations

Inoue, Takako, Takehisa Watanabe, & Yasuhito Tanaka. (2023). Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy. Clinical and Molecular Hepatology. 29(4). 851–868. 15 indexed citations

10.

Kunimasa, Kei, Toru Oka, Satoshi Hara, et al.. (2020). Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction. Lung Cancer. 153. 186–192. 24 indexed citations

11.

Kunimasa, Kei, Toru Oka, Makiko Oboshi, et al.. (2020). Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib. JACC CardioOncology. 2(1). 1–10. 58 indexed citations

12.

Inoue, Takako, Tatsuya Nishikawa, Kei Kunimasa, et al.. (2020). Infectious pericarditis caused by Gemella sanguinis induced by Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA): A case report. Respiratory Medicine Case Reports. 30. 101057–101057. 6 indexed citations

13.

Uchibori, Ken, Miyako Satouchi, Naoko Sueoka‐Aragane, et al.. (2018). Phase II trial of gefitinib plus pemetrexed after relapse using first-line gefitinib in patients with non-small cell lung cancer harboring EGFR gene mutations. Lung Cancer. 124. 65–70. 13 indexed citations

14.

Kumagai, Toru, Yasuhiko Tomita, Shin‐ichi Nakatsuka, et al.. (2018). HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1. Thoracic Cancer. 9(4). 466–471. 9 indexed citations

15.

Hata, Akito, Nobuyuki Katakami, Reiko Kaji, et al.. (2018). Afatinib plus bevacizumab combination after acquired resistance to EGFR tyrosine kinase inhibitors in EGFR ‐mutant non–small cell lung cancer: Multicenter, single‐arm, phase 2 trial (ABC Study). Cancer. 124(19). 3830–3838. 36 indexed citations

16.

Kimura, Madoka, Hiroko Endo, Takako Inoue, et al.. (2015). Analysis of ERBB Ligand-Induced Resistance Mechanism to Crizotinib by Primary Culture of Lung Adenocarcinoma with EML4-ALK Fusion Gene. Journal of Thoracic Oncology. 10(3). 527–530. 23 indexed citations

17.

Inoue, Takako. (2008). Between Art and Religion: Bhāgavata Mēla in Thanjavur. Senri ethnological studies. 71(71). 103–134. 2 indexed citations

18.

Seta, Sueshige, Takako Inoue, & Lars Strömberg. (1994). Foreword. Forensic Science International. 69(1). vii–viii. 1 indexed citations

19.

Inoue, Takako & Shinichi Suzuki. (1987). High-performance liquid chromatographic determination of triazolam and its metabolites in human urine. Journal of Chromatography B Biomedical Sciences and Applications. 422. 197–204. 18 indexed citations

20.

Inoue, Takako, Shin-ichi Suzuki, & Tetsukichi Niwaguchi. (1983). Stability of Perfluoroacyi Derivatives of Methamphetamine and Its Metabolites. Eisei kagaku. 29(6). 412–417. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact